|
|
|
|
Oxford Genome Sciences Changes its Name to Oxford BioTherapeutics
- Oxford Genome Sciences announced today that it has changed its name to Oxford BioTherapeutics (OBT).The new name will take effect immediately and comes at an exciting time in the Companys development as it continues to advance its...
|
|
|
DxS and Amgen enter into Collaboration to Provide a K-RAS Companion Diagnostic for VectibixR in the United Sta
- DxS, a personalised medicine company, has signed an agreement with Amgen Inc.to provide a K-RAS companion diagnostic for Vectibix (panitumumab) in the United States. Pursuant to the terms of the agreement, DxS and Amgen...
|
|
|
DxS and Amgen enter into Collaboration to Provide a K-RAS Companion Diagnostic for VectibixR in the United Sta
DxS, a personalised medicine company, has signed an agreement with Amgen Inc.to provide a K-RAS companion diagnostic for Vectibix (panitumumab) in the United States. Pursuant to the terms of the agreement, DxS and Amgen...
|
|
|
DxS And Amgen Enter Into Collaboration To Provide A K-RAS Companion Diagnostic For Vectibix(R) In The United S
, a personalised medicine company, has signed an agreement with Amgen Inc.to provide a K-RAS companion diagnostic for Vectibix (panitumumab) in the United States. Pursuant to the terms of the agreement, and Amgen shall work...
|
|
|
Former Amgen Exec Joins Accounting Firm in Woodland Hills
Woodland Hills-based accounting firm CNM, LLP announced it has hired former Amgen executive Carl Adams to head its Accounting & Transactions Advisory service line.Adams comes to CNM from director posts at Amgens SEC...
|
|
|
DxS and Amgen enter into Collaboration to Provide a K-RAS Companion Diagnostic for VectibixR in the United Sta
- DxS, a personalised medicine company, has signed an agreement with Amgen Inc.to provide a K-RAS companion diagnostic for Vectibix (panitumumab) in the United States. Pursuant to the terms of the agreement, DxS and Amgen...
|
|
|
New Citeline Analysis Finds Substantial Disparity In The Number Of Ongoing Clinical Trials For The Top 20 Biot
Biotech is reclaiming its buzzword status once again, and Citeline authors Christine Blazynski and Tracy DeGregorio look at the top 20 biotech companies in the December issue of GCPj and find significant disparity between the top five...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
BioTrends Research Group, Inc.released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and Canadian Nephrology. The report is...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
|
|
European Nephrologists Share Insights on the Management of Renal Anemia and Hyperphosphatemia in Latest BioTre
EXTON, Pa., Dec.1 /PRNewswire/ -- BioTrends Research Group, Inc. released its third TreatmentTrends(TM): European Nephrology Report. This report runs parallel to two ongoing studies BioTrends conducts -- TreatmentTrends(TM): US and...
|
